.

ISSN 2063-5346
For urgent queries please contact : +918130348310

EXPLORE THE DISSOCUBE TECHNOLOGY FOR INHIBIT ANTI HIV-I TARGET TO CD4 – T CELL BY NANOSUSPENSION

Main Article Content

Shubhrajit Mantry, Poonam Rajendra Bramhane, Kiran C. Mahajan, Shital Bidkar, Meher D.Abhishek, Ganesh Dama
» doi: 10.31838/ecb/2023.12. 4.126

Abstract

The human immune deficiency virus (HIV) is the causative agent of acquired immune deficiency syndrome (AIDS). According to Global HIV statistics, about 33.9 million- 43.8 million people were living with HIV in 2021. The development of effective antiretroviral drugs and the scientific accomplishments in HIV research over the past twenty-six years have been challenging. The pathogenesis of HIV disease is the basis of a decrease in the number of CD4-T cells. These ‘helper T cells are responsible for several roles for other immune residents, and their loss leads to profound immunosuppression

Article Details